Technical Analysis for TARA - ArTara Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
New Uptrend | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Outside Day | Range Expansion | 8.70% | |
Wide Bands | Range Expansion | 8.70% | |
Oversold Stochastic | Weakness | 8.70% | |
New Downtrend | Bearish | 12.04% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 16 hours ago |
20 DMA Resistance | about 20 hours ago |
Up 10% | about 20 hours ago |
Up 1 ATR | about 20 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
ArTara Therapeutics, Inc., a clinical-stage company, develops product candidates for patients suffering from rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The company's lead program is TARA-002, a cellular therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. ArTara Therapeutics, Inc. is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Hepatology Liver Disease Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Hepatology Liver Disease Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.95 |
52 Week Low | 1.04 |
Average Volume | 79,585 |
200-Day Moving Average | 2.29 |
50-Day Moving Average | 3.17 |
20-Day Moving Average | 4.07 |
10-Day Moving Average | 3.74 |
Average True Range | 0.38 |
RSI (14) | 57.26 |
ADX | 32.03 |
+DI | 23.73 |
-DI | 18.35 |
Chandelier Exit (Long, 3 ATRs) | 3.82 |
Chandelier Exit (Short, 3 ATRs) | 4.45 |
Upper Bollinger Bands | 4.86 |
Lower Bollinger Band | 3.28 |
Percent B (%b) | 0.46 |
BandWidth | 38.84 |
MACD Line | 0.13 |
MACD Signal Line | 0.24 |
MACD Histogram | -0.1049 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.61 | ||||
Resistance 3 (R3) | 4.58 | 4.36 | 4.51 | ||
Resistance 2 (R2) | 4.36 | 4.20 | 4.37 | 4.47 | |
Resistance 1 (R1) | 4.18 | 4.11 | 4.27 | 4.20 | 4.44 |
Pivot Point | 3.95 | 3.95 | 4.00 | 3.96 | 3.95 |
Support 1 (S1) | 3.77 | 3.80 | 3.86 | 3.80 | 3.56 |
Support 2 (S2) | 3.55 | 3.70 | 3.56 | 3.53 | |
Support 3 (S3) | 3.37 | 3.55 | 3.49 | ||
Support 4 (S4) | 3.39 |